These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21894174)

  • 61. Obesity and cancer: mechanistic insights from transdisciplinary studies.
    Allott EH; Hursting SD
    Endocr Relat Cancer; 2015 Dec; 22(6):R365-86. PubMed ID: 26373570
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database.
    Moreira DM; Cooperberg MR; Howard LE; Aronson WJ; Kane CJ; Terris MK; Amling CL; Kuchibhatla M; Freedland SJ
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):91-6. PubMed ID: 24418913
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Boffetta P; Freedland SJ
    Cancer; 2014 Jan; 120(2):197-204. PubMed ID: 24127391
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
    Allott EH; Abern MR; Gerber L; Keto CJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Moorman PG; Freedland SJ
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):391-7. PubMed ID: 24100644
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression.
    Lloyd JC; Masko EM; Wu C; Keenan MM; Pilla DM; Aronson WJ; Chi JT; Freedland SJ
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):285-91. PubMed ID: 23877027
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Obesity and prostate cancer: weighing the evidence.
    Allott EH; Masko EM; Freedland SJ
    Eur Urol; 2013 May; 63(5):800-9. PubMed ID: 23219374
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database.
    Moreira DM; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2010 Jan; 105(1):28-33. PubMed ID: 19522861
    [TBL] [Abstract][Full Text] [Related]  

  • 68. BMI is associated with larger index tumors and worse outcome after radical prostatectomy.
    Hayashi N; Matsushima M; Kido M; Naruoka T; Furuta A; Furuta N; Takahashi H; Egawa S
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):233-7. PubMed ID: 24841331
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
    Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ; Hotaling JM; Fitzsimons NJ; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL
    Eur Urol; 2008 Apr; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database.
    Whitley BM; Moreira DM; Thomas JA; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ;
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):361-6. PubMed ID: 21894174
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.